Studies will be carried out on the mechanisms by which polyoma virus's middle T and small t antigens transform cultured fibroblasts. Middle T is thought to transform by binding to and modulating the activities of certain key cellular proteins. Similarly small t is thought to carry out its helper role in transformation via binding host cell proteins. In the past the identification and study of these cellular proteins has been a facile and efficient route to knowledge about intracellular signaling pathways involved in growth factor action and transformation. The applicant's studies in the current grant period will focus on three complementary aspects of middle T antigen: First a series of newly developed techniques will be utilized to search for additional cellular proteins which are bound by middle and small t antigens. Second he will continue our work on two known binding proteins, Pi 3 kinase and hsc70. In the case of Pi3 kinase he will define the mechanisms by which it causes enhanced apoptosis in Rat 1 fibroblasts and down regulates EGF receptor function. In the case of hsc70 he will study how its binding partner on T antigens, the so called dnaJ domain, functions in small and middle T. Finally he will utilize a newly developed class of middle T mutations, the Rescue Mutants, to extend the use of Middle T in studying cellular signaling.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA030002-23
Application #
6709424
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2000-04-01
Project End
2005-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
23
Fiscal Year
2004
Total Cost
$394,523
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Cizmecioglu, Onur; Ni, Jing; Xie, Shaozhen et al. (2016) Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. Elife 5:
Rouleau, Cecile; Pores Fernando, Arun T; Hwang, Justin H et al. (2016) Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. J Virol 90:7032-7045
Hashim, D; Sartori, S; Brennan, P et al. (2016) The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Ann Oncol 27:1619-25
Pores Fernando, A T; Andrabi, S; Cizmecioglu, O et al. (2015) Polyoma small T antigen triggers cell death via mitotic catastrophe. Oncogene 34:2483-92
Utermark, Tamara; Schmit, Fabienne; Lee, Sang Hyun et al. (2014) The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type. J Virol 88:10673-9
Hwang, Justin H; Pores Fernando, Arun T; Faure, Nathalie et al. (2014) Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation. J Virol 88:12055-64
Schmit, Fabienne; Utermark, Tamara; Zhang, Sen et al. (2014) PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context. Proc Natl Acad Sci U S A 111:6395-400
Jia, Shidong; Gao, Xueliang; Lee, Sang Hyun et al. (2013) Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention. Cancer Discov 3:44-51
Utermark, Tamara; Rao, Trisha; Cheng, Hailing et al. (2012) The p110ýý and p110ýý isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis. Genes Dev 26:1573-86
Ni, Jing; Liu, Qingsong; Xie, Shaozhen et al. (2012) Functional characterization of an isoform-selective inhibitor of PI3K-p110? as a potential anticancer agent. Cancer Discov 2:425-33

Showing the most recent 10 out of 65 publications